Your browser doesn't support javascript.
loading
Cost effectiveness of pharmacogenetic-guided clozapine administration based on risk of HLA variants in Japan and the UK.
Ninomiya, Kohei; Saito, Takeo; Okochi, Tomo; Taniguchi, Satoru; Shimasaki, Ayu; Aoki, Rei; Hata, Takeo; Mushiroda, Taisei; Kanazawa, Tetsufumi; Ikeda, Masashi; Iwata, Nakao.
Afiliação
  • Ninomiya K; Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
  • Saito T; Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
  • Okochi T; Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
  • Taniguchi S; Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
  • Shimasaki A; Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
  • Aoki R; Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
  • Hata T; Department of Pharmacy, Osaka Medical College Hospital, Takatsuki, Osaka, Japan.
  • Mushiroda T; Laboratory for Pharmacogenomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Kanazawa T; Department of Neuropsychiatry, Osaka Medical College, Takatsuki, Osaka, Japan.
  • Ikeda M; Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan. ikeda-ma@fujita-hu.ac.jp.
  • Iwata N; Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
Transl Psychiatry ; 11(1): 362, 2021 07 07.
Article em En | MEDLINE | ID: mdl-34230449

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Clozapina Tipo de estudo: Etiology_studies / Guideline / Health_economic_evaluation / Risk_factors_studies Limite: Humans País/Região como assunto: Asia / Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Clozapina Tipo de estudo: Etiology_studies / Guideline / Health_economic_evaluation / Risk_factors_studies Limite: Humans País/Região como assunto: Asia / Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article